Vital Signs

  1. This issue of Vital Signs, released on Novemeber 7, 2011, provides a strategic insight on the ultrasound market. Additionally, a company spotlight is provided for Signostics, an international medical device company with a mission to provide clinicians with affordable handheld tools for use at the point of care. Reimbursement and regulatory news ...

    $1,500.00
  2. This issue of Vital Signs, released on October 17, 2011, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Pharmaceuticals and Biotechnology, Medical Devices, Patient Monitoring, Healthcare IT, and Medical Imaging.

    $1,500.00
  3. This issue of Vital Signs, released on October 14, 2011, provides a strategic insight on health-enabled devices market. Additionally, a company spotlight is provided for Second Sight, a a privately held company based out of Sylamar, California focused on the development of novel implantable visual prosthetics. Reimbursement and regulatory news ...

    $1,500.00
  4. This issue of Vital Signs, released on Oct 5th, 2011, discusses the growing need for advanced data analytics within U.S. healthcare provider organizations, particularly hospitals. This article reviews the major drivers of this important trend. It provides insights into how traditional business intelligence, used primarily to report metrics around f...

    $1,500.00
  5. This issue of Vital Signs, released on September 12, 2011, provides a strategic insight on injectable drug delivery market. Additionally, a company spotlight is provided for Unilife Medical Solutions, a U.S. based medical device company specializing in the design and development of innovative and safe drug and vaccine injection systems. Reimburs...

    $1,500.00
  6. This issue of Vital Signs, released on August 22, 2011, provides a strategic insight on enterprise imaging IT market. Additionally, a company spotlight is provided for RealTime Medical, which has developed patent-pending, cloud-based, and interoperable eDiagnosis software platforms and solutions that enable hospitals, clinics, groups of speciali...

    $1,500.00
  7. This issue of Vital Signs, released on July 18, 2011, provides a strategic insight on the health and wellness market. Additionally, a company spotlight is provided for Dymedix Corporation, a medical device company, produces reusable and disposable sensors and electrodes for sleep diagnostic testing. Reimbursement and regulatory news from the FDA...

    $1,500.00
  8. This issue of Vital Signs, released on July 6, 2011, provides a strategic insight on the molecular diagnostics market. Additionally, a company spotlight is provided for Stratos Genomics, a company that is developing a next generation DNA sequencing technology that enables accurate and ultra-low cost whole genome sequencing non-invasive imaging s...

    $1,500.00
  9. This issue of Vital Signs, released on 20 June 2011, provides on overview of the challenges hospitals and physicians are facing with the need to connect and aggregate electronic health data from a variety of dispersed care settings. This 10-page article discusses why the need for effective technology solutions for data integration is growing as a r...

    $1,500.00
  10. This issue of Vital Signs, released on June 13, 2011, provides a strategic insight on the personalized medicine market in medical imaging. Additionally, a company spotlight is provided for TechniScan Medical Systems, a publicly traded medical device company that has developed a non-invasive imaging system that provides automated ultrasound images ...

    $1,500.00